With the general election looming, increasingly the question is becoming one of judgement. Who do we trust to represent the country and with that, the economy? The UK economy is consumption led, meaning that what happens in retail and consumer goods and services, is significant, when looking at economic activity. With that, in what is turning out to be a spectacular own goal, the Government’s ill fated ‘tourist tax’ on retail (not allowing VAT rebates on shopping) is starting to be felt amongst retailers.
For the UK Pharmaceuticals industry, the headwinds are real. The post pandemic hangover, at first caused by clinical trials being delayed on approval, so that COVID-19 related drugs could be prioritised meant that as the pandemic subsided, the pipeline of other drugs going to clinical trials had slowed to a trickle. The MHRA was supposedly tasked with creating a fast track regime to overcome this, equally even now, the EMA is approving drugs faster. Hence for pharmaceuticals companies looking at where they should organise trials, the UK is as a result, less attractive.
Now that the economic data released, shows that we are out of recession, as an update on what we are seeing, what is noteworthy as an indicator of market confidence, is that the leading role type being recruited for, now across the region, in 2024 so far, is for corporate b2b sales positions.
It is important that both Sales and Marketing teams are aware of who is doing what and how the business benefits from it. I found that regular meetings worked very well for us. This is a forum where both teams are discussing what they are up to and how Marketing can support Sales, or where Sales gives feedback on what worked and what didn`t.
